Massachusetts General Hospital Comprehensive Clinical Psychiatry
- 3rd Edition - March 6, 2024
- Editors: Theodore A. Stern, Timothy E. Wilens, Maurizio Fava
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 1 8 4 4 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 1 8 4 5 - 6
The Massachusetts General Hospital is widely regarded as one of the world's premier psychiatric institutions. Massachusetts General Hospital Comprehensive Clinical Psychiatry, 3r… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Massachusetts General Hospital is widely regarded as one of the world's premier psychiatric institutions. Massachusetts General Hospital Comprehensive Clinical Psychiatry, 3rd Edition, offers practical, informative, and hands-on advice from the staff of the esteemed MGH Department of Psychiatry, helping you put today’s best practices to work for your patients. This authoritative reference covers a wide variety of clinical syndromes and settings, aided by superb graphics throughout. In one convenient volume, you’ll have easy access to the answers you need to face and overcome any clinical challenge.
- Uses a reader-friendly and highly templated format with abundant boxed summaries, bulleted points, case histories, algorithms, references, and suggested readings.
- Contains new chapters on the Psychiatric Management of Patients with Cardiac, Renal, Pulmonary, and Gastrointestinal Disease; COVID-19 Infection; Burns, Trauma, and Intensive Care Unit Treatment; Care of LGBTQ Patients; and Mindfulness and Resilience.
- Covers key areas, such as Substance Use Disorders; Mood, Anxiety, and Psychotic Disorders; Emergency Psychiatry; Functional Neuroanatomy and the Neurologic Examination; Psychological and Neuropsychological Assessment; Military Psychiatry; Psychiatric Manifestations of Traumatic Brain Injury; Legal and Ethical Issues in Psychiatry; End of Life Care; and Approaches to Collaborative Care and Primary Care Psychiatry.
- Features key points for every chapter, updated DSM-5 criteria, and enhanced content on collaborative care and behavioral medicine, ensuring that your knowledge is thorough and up to date.
- Corresponds to the companion review volume, Massachusetts General Hospital Study Guide for Psychiatry Exams, 2nd Edition (ISBN: 978-0-443-11983-5).
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
Practicing psychiatrists
- Cover image
- Title page
- Table of Contents
- Any screen, Any time, Anywhere
- Copyright
- Dedication
- Contributors
- Preface
- Part I: Approach to the Patient
- 1. The Doctor–Patient Relationship
- OVERVIEW
- COLLABORATING AROUND HISTORY-TAKING
- PLANNING THE PATH FORWARD: CREATING A CLINICAL FORMULATION
- TREATMENT PLANNING
- OBSTACLES AND DIFFICULTIES IN THE DOCTOR–PATIENT RELATIONSHIP
- REFERENCES
- 2. The Psychiatric Interview
- OVERVIEW
- LESSONS FROM ATTACHMENT THEORY, NARRATIVE MEDICINE, AND MINDFUL PRACTICE
- THE CONTEXT OF THE INTERVIEW: FACTORS INFLUENCING THE FORM AND CONTENT OF THE INTERVIEW
- ESTABLISHING AN ALLIANCE AND FOSTERING EFFECTIVE COMMUNICATION
- BUILDING THE RELATIONSHIP AND THERAPEUTIC ALLIANCE
- DATA COLLECTION: BEHAVIORAL OBSERVATION, THE MEDICAL AND PSYCHIATRIC HISTORY, AND THE MENTAL STATUS EXAMINATION
- SHARING INFORMATION AND PREPARING THE PATIENT FOR TREATMENT
- THE EVALUATION OF CHILDREN AND ADOLESCENTS
- DIFFICULTIES AND ERRORS IN THE PSYCHIATRIC INTERVIEW
- REFERENCES
- 3. Laboratory Tests and Diagnostic Procedures
- OVERVIEW
- A GENERAL APPROACH TO CHOOSING LABORATORY TESTS AND DIAGNOSTIC STUDIES
- ROUTINE SCREENING
- PSYCHOSIS AND DELIRIUM
- ANXIETY DISORDERS
- MOOD DISORDERS
- METABOLIC AND NUTRITIONAL
- NEUROENDOCRINE DISORDERS
- IMMUNE DISORDERS
- INFECTIOUS DISEASES
- DEGENERATIVE DISORDERS
- SUBSTANCE USE DISORDERS
- TOXINS
- EATING DISORDERS
- DRUG MONITORING
- ELECTROENCEPHALOGRAM
- NEUROIMAGING
- STRUCTURAL NEUROIMAGING
- CONCLUSION
- REFERENCES
- 4. Treatment Adherence
- OVERVIEW
- EPIDEMIOLOGY OF ADHERENCE
- CLINICAL AND ECONOMIC IMPACT OF NON-ADHERENCE
- RISK FACTORS FOR NON-ADHERENCE
- ASSESSING ADHERENCE
- INTEGRATING ADHERENCE INTO THE TREATMENT COURSE
- PROBLEM-SOLVING BARRIERS TO ADHERENCE
- FUTURE DIRECTIONS
- CONCLUSION
- References
- Part II: Human Development
- 5. Child, Adolescent, and Adult Development
- OVERVIEW
- MAJOR THEORIES OF DEVELOPMENT
- BRAIN DEVELOPMENT
- REFERENCES
- Part III: Rating Scales and Psychological/Neuropsychological Testing
- 6. Diagnostic Rating Scales and Psychiatric Instruments
- OVERVIEW
- GENERAL CONSIDERATIONS IN THE SELECTION OF DIAGNOSTIC RATING SCALES
- GENERAL DIAGNOSTIC INSTRUMENTS
- SCALES FOR MOOD DISORDERS
- SCALES FOR PSYCHOTIC DISORDERS
- SCALES FOR ANXIETY DISORDERS
- SCALES FOR SUBSTANCE USE DISORDERS
- SCALES FOR COGNITIVE DISORDERS
- CONCLUSION
- REFERENCES
- 7. Understanding and Applying Psychological Assessment
- OVERVIEW
- PSYCHOMETRICS: THE SCIENCE OF PSYCHOLOGICAL MEASUREMENT
- MAJOR CATEGORIES OF PSYCHOLOGICAL TESTS
- THE ASSESSMENT CONSULTATION PROCESS AND REPORT
- REFERENCES
- 8. Neuropsychological Assessment
- INTRODUCTION
- DIMENSIONS OF BEHAVIOR ASSESSED
- BRIEF NEUROPSYCHOLOGICAL SCREENING MEASURES
- CONCLUSION
- ACKNOWLEDGMENTS
- REFERENCES
- Part IV: The Psychotherapies
- 9. Coping with Medical Illness and Psychotherapy of the Medically Ill Patients
- BACKGROUND
- HISTORY
- CLINICAL AND RESEARCH CHALLENGES
- PRACTICAL POINTERS
- REFERENCES
- 10. An Overview of the Psychotherapies
- BACKGROUND
- PSYCHODYNAMIC PSYCHOTHERAPY
- COGNITIVE-BEHAVIORAL THERAPY
- SUPPORTIVE PSYCHOTHERAPY
- BRIEF PSYCHOTHERAPY
- PSYCHIATRIC MEDICATION WITH PSYCHOTHERAPY
- INTERPERSONAL PSYCHOTHERAPY
- DIALECTICAL BEHAVIOR THERAPY
- GROUP THERAPY
- COUPLES THERAPY
- INTEGRATIVE PSYCHOTHERAPY
- INNOVATIVE DIRECTIONS OF PSYCHOTHERAPY RESEARCH
- CHILD AND ADOLESCENT PSYCHOTHERAPY
- MANUAL-DRIVEN THERAPIES AND BEHAVIORAL THERAPIES
- SYSTEMS-BASED CARE
- CONCLUSION
- REFERENCES
- 11. Brief Psychotherapy: An Overview
- OVERVIEW
- HISTORY OF BRIEF PSYCHOTHERAPY
- MODERN BRIEF PSYCHOTHERAPIES
- THE ESSENTIAL FEATURES OF BRIEF THERAPY
- REFERENCES
- 12. Couples Therapy
- OVERVIEW
- SEMINAL IDEAS IN COUPLES THERAPY
- IDENTIFICATION OF DYSFUNCTIONAL RELATIONAL PATTERNS
- MATE CHOICE AND THE CONTRIBUTION OF ONE’S FAMILY OF ORIGIN
- COMMUNICATION
- INTIMACY AND CONTROL
- LIFE CYCLE CONTEXT AND TRANSITION POINTS
- CONDUCTING A COUPLES THERAPY EVALUATION
- COUPLES THERAPY TECHNIQUES
- CONCLUSION
- REFERENCES
- 13. Family Therapy
- OVERVIEW
- PSYCHODYNAMIC FAMILY THERAPY
- EXPERIENTIAL FAMILY THERAPY
- STRUCTURAL FAMILY THERAPY
- STRATEGIC FAMILY THERAPY
- SYSTEMIC FAMILY THERAPY
- NARRATIVE FAMILY THERAPY
- BEHAVIORAL FAMILY THERAPY
- PSYCHOEDUCATIONAL FAMILY THERAPY
- THE MAUDSLEY MODEL: AN EXAMPLE OF THEORY INTEGRATION
- CONCLUSION
- REFERENCES
- 14. Group Psychotherapy
- OVERVIEW
- CREATING A GROUP
- CLINICAL VIGNETTE
- WHO SHOULD BE TREATED IN GROUP THERAPY?
- COMBINED THERAPIES
- LEGAL AND ETHICAL CONSIDERATIONS IN GROUP THERAPY
- RESEARCH, OUTCOME, AND EVALUATION
- CONSULTATION AND SUPERVISION FOR GROUP THERAPY
- REFERENCES
- 15. Cognitive-Behavioral Therapy, Behavioral Therapy, and Cognitive Therapy
- OVERVIEW
- BEHAVIORAL THERAPY, COGNITIVE THERAPY, AND COGNITIVE-BEHAVIORAL THERAPY
- PUTTING BEHAVIORAL THERAPY AND COGNITIVE THERAPY TOGETHER
- THE EFFICACY OF COGNITIVE-BEHAVIORAL THERAPY
- COMBINING COGNITIVE-BEHAVIORAL THERAPY WITH MEDICATION
- RECENT DEVELOPMENTS AND FUTURE DIRECTIONS
- CONCLUSION
- References
- Part V: Disorders of Cognition
- 16. Delirium
- OVERVIEW
- DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- EXAMINATION OF THE PATIENT
- SPECIFIC MANAGEMENT STRATEGIES FOR DELIRIUM
- PHARMACOLOGICAL DELIRIUM SYMPTOM MANAGEMENT
- PHARMACOLOGICAL MANAGEMENT IN SPECIFIC SETTINGS
- DELIRIUM PREVENTION AND RISK STRATIFICATION
- CONCLUSIONS
- REFERENCES
- 17. Neurocognitive Disorders and Dementia
- OVERVIEW
- EPIDEMIOLOGY OF DEMENTIA
- THE ROLE OF AGE OF ONSET
- EVALUATION OF A PATIENT WITH SUSPECTED COGNITIVE IMPAIRMENT
- ALZHEIMER’S DISEASE
- LEWY BODY DEMENTIA
- FRONTOTEMPORAL DEMENTIAS
- VASCULAR DEMENTIA
- CORTICOBASAL DEGENERATION
- PROGRESSIVE SUPRANUCLEAR PALSY
- NORMAL-PRESSURE HYDROCEPHALUS
- RAPIDLY PROGRESSING DEMENTIAS: PRION DISEASES WITH CREUTZFELDT–JAKOB DISEASE AS AN EXAMPLE
- CONCLUSIONS
- REFERENCES
- 18. Intellectual Disability
- OVERVIEW
- EPIDEMIOLOGY
- CO-MORBID PSYCHOPATHOLOGY
- CLINICAL FEATURES AND DIAGNOSIS
- TREATMENT CONSIDERATIONS
- CONCLUSION
- REFERENCES
- Part VI: Psychiatric Diagnoses and Conditions
- 19. The DSM-5 and DSM-5-Text Revision: A System for Psychiatric Diagnosis
- THE DSM-5 AND DSM-5-TR IN CONTEXT: AN EVOLVING DIAGNOSTIC SYSTEM
- CRITIQUES AND LIMITATIONS OF THE DSM-5 AND DSM-5-TR
- CONCLUSION
- REFERENCES
- 20. Psychiatric Neuroscience: Incorporating Pathophysiology into Clinical Case Formulation
- OVERVIEW
- PSYCHIATRIC DIAGNOSIS: BIOMARKERS AND BIOLOGICAL VALIDITY
- METHODS IN PSYCHIATRIC NEUROSCIENCE
- BIOLOGICAL CASE FORMULATION: NEUROSCIENTIFIC CONTENT AND PROCESS
- GENES, ENVIRONMENT, AND EPIGENETICS
- OVERVIEW OF THE STRUCTURE OF THE CENTRAL NERVOUS SYSTEM
- CELLULAR DIVERSITY IN THE BRAIN: NEURONS AND GLIA
- THE STRUCTURE OF THE SYNAPSE
- A REVIEW OF CLINICALLY RELEVANT NEUROTRANSMITTER SYSTEMS
- CONCLUSION
- REFERENCES
- 21. Mental Disorders Due to Another Medical Condition
- OVERVIEW
- DISORDERS
- PSYCHIATRIC DIFFERENTIAL DIAGNOSIS
- EVALUATION
- TREATMENT CONSIDERATIONS AND STRATEGIES
- CONCLUSIONS
- REFERENCES
- 22. Sleep Disorders
- OVERVIEW
- SLEEP ARCHITECTURE
- SLEEP PHYSIOLOGY
- SLEEP INVESTIGATIONS
- Sleep–Wake Disorders
- Narcolepsy
- REFERENCES
- 23. Disruptive, Impulse-Control, and Conduct Disorders
- OVERVIEW
- OPPOSITIONAL DEFIANT DISORDER AND CONDUCT DISORDER
- INTERMITTENT EXPLOSIVE DISORDER
- KLEPTOMANIA
- PYROMANIA
- GAMBLING DISORDER
- TRICHOTILLOMANIA
- CONCLUSION
- REFERENCES
- 24. Somatic Symptom Disorders
- OVERVIEW
- CROSS-WALKING DSM-IV TO DSM-5
- TREATMENT
- CONCLUSIONS
- REFERENCES
- 25. Factitious Disorders and Malingering
- OVERVIEW
- FACTITIOUS DISORDERS
- FACTITIOUS DISORDER IMPOSED ON SELF
- FACTITIOUS DISORDER IMPOSED ON ANOTHER
- MALINGERING
- CONFRONTATION OF DECEPTIVE PATIENTS
- CONCLUSION
- REFERENCES
- 26. Substance Use Disorders
- OVERVIEW
- ALCOHOL USE DISORDER AND RELATED CONDITIONS
- COCAINE USE DISORDER AND ASSOCIATED CONDITIONS
- AMPHETAMINE USE DISORDER
- CLUB DRUGS
- OPIOID USE DISORDER AND ASSOCIATED CONDITIONS
- BENZODIAZEPINES AND BARBITURATES
- REFERENCES
- 27. Psychosis and Schizophrenia
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- PATHOPHYSIOLOGY
- DIAGNOSIS AND CLINICAL FEATURES
- EVALUATION
- DIFFERENTIAL DIAGNOSIS OF PSYCHOSIS
- REHABILITATION AND LONG-TERM MANAGEMENT
- PROGNOSIS
- REFERENCES
- 28. Depressive Disorders
- OVERVIEW
- MAJOR DEPRESSIVE DISORDER
- SUBTYPES OF MAJOR DEPRESSIVE DISORDER
- EVALUATION OF PATIENTS WHO MIGHT HAVE MAJOR DEPRESSIVE DISORDER
- OTHER DEPRESSIVE DISORDERS
- EPIDEMIOLOGY OF MAJOR DEPRESSIVE DISORDER
- MORBIDITY, DISABILITY, AND MORTALITY RATES IN DEPRESSION
- IMPACT OF DEPRESSION ON MEDICAL CO-MORBIDITY
- IMPACT OF NON-PSYCHIATRIC MEDICAL ILLNESSES ON MAJOR DEPRESSIVE DISORDER
- DEPRESSION AND PRIMARY CARE
- RISK FACTORS OF DEPRESSION IN PRIMARY CARE
- ASSOCIATED FEATURES OF DEPRESSION IN PRIMARY CARE
- INDICATION FOR REFERRAL TO PSYCHIATRISTS
- CONCLUSIONS
- REFERENCES
- 29. Bipolar Disorder
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- HISTORICAL CONTEXT
- CLINICAL FEATURES AND PHENOMENOLOGY
- ASSOCIATED ILLNESS FEATURES
- FEATURES OF LONGITUDINAL COURSE
- NEUROBIOLOGY AND PATHOPHYSIOLOGY
- EVALUATION, TESTS, AND LABORATORY WORK-UP
- TREATMENT
- SPECIAL CONSIDERATIONS IN TREATMENT
- REFERENCES
- 30. Psychiatric Illness During Pregnancy and the Post-partum Period
- OVERVIEW
- PRECONCEPTION CONSIDERATIONS
- SCREENING AND DIAGNOSIS OF DEPRESSION AND ANXIETY DURING PREGNANCY
- TREATMENT OF DEPRESSION DURING PREGNANCY: CLINICAL GUIDELINES
- ELECTROCONVULSIVE THERAPY DURING PREGNANCY
- MOOD STABILIZERS DURING PREGNANCY
- TREATMENT OF BIPOLAR DURING PREGNANCY: CLINICAL GUIDELINES
- PSYCHOTIC DISORDERS DURING PREGNANCY
- ANXIETY DISORDERS DURING PREGNANCY
- ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND PREGNANCY
- CANNABIS USE DURING PREGNANCY
- POSTPARTUM MOOD AND ANXIETY DISORDERS: DIAGNOSIS AND TREATMENT
- PREVENTION OF POSTPARTUM PSYCHIATRIC DISORDERS
- BREASTFEEDING AND PSYCHOTROPIC DRUG USE
- REFERENCES
- 31. Anxiety Disorders and Post-traumatic Stress Disorder
- ANXIETY DISORDERS
- PANIC DISORDER AND AGORAPHOBIA
- SOCIAL ANXIETY DISORDER
- GENERALIZED ANXIETY DISORDER
- IMPAIRMENT AND QUALITY OF LIFE ASSOCIATED WITH ANXIETY DISORDERS
- CO-MORBIDITY IN ANXIETY DISORDERS
- PATHOPHYSIOLOGY OF ANXIETY DISORDERS
- TREATMENT
- CURRENT CONTROVERSIES AND FUTURE DIRECTIONS
- POST-TRAUMATIC STRESS DISORDER
- ACUTE STRESS DISORDER
- IMPAIRMENT AND QUALITY OF LIFE ASSOCIATED WITH PTSD
- TREATMENT
- CURRENT CONTROVERSIES AND FUTURE DIRECTIONS
- CONCLUSION
- REFERENCES
- 32. Obsessive-Compulsive and Related Disorders
- OVERVIEW
- OBSESSIVE-COMPULSIVE DISORDER
- HOARDING DISORDER
- BODY DYSMORPHIC DISORDER
- HAIR-PULLING AND SKIN-PICKING DISORDER
- FUTURE DIRECTIONS
- CLINICIAN AND PATIENT RESOURCES
- REFERENCES
- SUGGESTED READING
- 33. Dissociative Disorders
- OVERVIEW
- CAUSES OF DISSOCIATION
- THE EPIDEMIOLOGY OF DISSOCIATION
- DIFFERENT DISSOCIATIVE DISORDERS
- FACTITIOUS DISORDERS OR MALINGERING OF DISSOCIATIVE PRESENTATIONS
- CONCLUSION
- REFERENCES
- 34. Sexual Disorders and Sexual Dysfunction
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- PATHOPHYSIOLOGY
- CLINICAL FEATURES AND DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS OF SEXUAL DISORDERS
- TREATMENT
- OUTLOOK
- REFERENCES
- 35. Eating Disorders: Evaluation and Management
- OVERVIEW
- CLASSIFICATION
- EPIDEMIOLOGY
- ETIOLOGICAL FACTORS
- DIAGNOSTIC FEATURES
- PSYCHIATRIC EVALUATION
- MEDICAL COMPLICATIONS
- MEDICAL ASSESSMENT
- TREATMENT APPROACH
- MEDICAL MANAGEMENT
- PSYCHOTHERAPEUTIC TREATMENT
- PHARMACOLOGICAL TREATMENT
- CONCLUSIONS
- CURRENT CONTROVERSIES AND FUTURE CONSIDERATIONS
- REFERENCES
- 36. Grief, Bereavement, and Adjustment Disorders
- GRIEF AND BEREAVEMENT
- ADJUSTMENT DISORDERS
- REFERENCES
- 37. Personality and Personality Disorders
- OVERVIEW
- PERSONALITY THEORY
- THE ORIGINS OF PERSONALITY
- ADULT PERSONALITY TRAITS
- DSM-5 PERSONALITY DISORDERS
- DIAGNOSING PERSONALITY DISORDERS
- TREATMENT OF PERSONALITY DISORDERS
- REFERENCES
- 38. Catatonia, Neuroleptic Malignant Syndrome, and Serotonin Syndrome
- OVERVIEW
- CATATONIA
- NEUROLEPTIC MALIGNANT SYNDROME
- SEROTONIN SYNDROME
- REFERENCES
- 39. Child and Adolescent Psychiatric Disorders
- OVERVIEW
- DEVELOPMENTAL VARIATIONS IN PSYCHOPATHOLOGY
- CHILDHOOD ANXIETY DISORDERS
- TIC DISORDERS
- ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
- OPPOSITIONAL DEFIANT DISORDER
- MOOD DISORDERS
- AUTISM SPECTRUM DISORDER
- PSYCHOTIC DISORDERS
- GENDER DIVERSITY
- REFERENCES
- Part VII: Psychosomatic Medicine
- 40. Psychiatric Management of Patients with Cardiac Disease
- OVERVIEW
- ANXIETY AND RELATED DISORDERS IN CARDIAC PATIENTS
- DEPRESSION IN CARDIAC PATIENTS
- DELIRIUM IN CARDIAC PATIENTS
- SEVERE MENTAL ILLNESS AND CARDIAC DISEASE
- CRITICAL ISSUES IN PSYCHOPHARMACOLOGY AND CARDIAC HEALTH
- REFERENCES
- 41. Psychiatric Management of Patients with Renal Disease
- INTRODUCTION
- PATIENTS WITH NORMAL KIDNEY FUNCTION
- KIDNEY DISEASE
- THERAPEUTIC OPTIONS FOR ADVANCED KIDNEY DISEASE
- PSYCHIATRIC DISORDERS IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE
- PSYCHIATRIC TREATMENT CONSIDERATIONS FOR PATIENTS WITH CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE
- REFERENCES
- 42. Psychiatric Management of Patients with Gastrointestinal Disease
- INTRODUCTION
- DISORDERS OF THE ESOPHAGUS, STOMACH, AND UPPER INTESTINES
- DISORDERS OF THE LOWER GASTROINTESTINAL TRACT
- PSYCHIATRIC ISSUES RELATED TO CANCERS OF THE UPPER AND LOWER INTESTINES
- LIVER DISORDERS
- DISORDERS OF THE PANCREAS
- MEDICATION CONSIDERATIONS IN GASTROINTESTINAL ILLNESS
- MEDICATION CONSIDERATIONS IN LIVER DISEASE
- REFERENCES
- 43. Pre-transplant Assessment and Post-transplant Management
- OVERVIEW
- PSYCHIATRIC EVALUATION OF TRANSPLANT PATIENTS
- TREATMENT OF PRE-TRANSPLANT PATIENTS
- CARE OF POST-TRANSPLANT PATIENTS
- PEDIATRIC TRANSPLANTATION
- CONCLUSION
- REFERENCES
- 44. HIV Infection and AIDS
- OVERVIEW
- EPIDEMIOLOGY
- BASIC BIOLOGY
- CLASSIFICATION AND DIAGNOSIS
- GENERAL APPROACH TO PSYCHIATRIC CARE
- PSYCHIATRIC DISORDERS
- COGNITIVE DISORDERS
- NEUROLOGICAL DISORDERS
- TREATMENT
- SPECIAL CLINICAL PROBLEMS
- INTERNET RESOURCES
- REFERENCES
- 45. COVID-19 Infection
- INTRODUCTION
- ACUTE NEUROPSYCHIATRIC SEQUELAE OF COVID-19 INFECTION
- WORK-UP FOR ACUTE NEUROPSYCHIATRIC SYMPTOMS
- SUBACUTE TO LONG-TERM SEQUELAE OF COVID-19 INFECTION
- RESEARCH TRIALS
- CONCLUSIONS
- REFERENCES
- 46. Psychiatric Co-morbidities and Complications of Cancer and Cancer Treatment
- PSYCHO-ONCOLOGY
- EMOTIONAL DISTRESS
- ANXIETY
- NAUSEA AND VOMITING
- SLEEP DISTURBANCES
- DEPRESSION
- FATIGUE
- NEUROPSYCHIATRIC SYMPTOMS AND SEQUELAE IN CANCER
- END-OF-LIFE CARE
- SURVIVORSHIP IN CANCER
- CONCLUSION
- REFERENCES
- 47. Psychiatric Care of Patients with Pulmonary Disease
- OVERVIEW
- PSYCHIATRIC IMPACT OF PULMONARY CONDITIONS
- PSYCHIATRIC IMPACT OF PULMONARY THERAPIES
- PRESENTATION AND TREATMENT OF PSYCHIATRIC DISORDERS ASSOCIATED WITH PULMONARY CONDITIONS
- CONSIDERATIONS FOR PRESCRIBING PSYCHOPHARMACOLOGIC AGENTS IN THE CONTEXT OF PULMONARY DISEASE
- IMPLICATIONS FOR LUNG TRANSPLANT EVALUATIONS
- REFERENCES
- 48. Burns, Trauma, and Intensive Care Unit Treatment
- BURN INJURIES
- Traumatic Injuries and Intensive Care
- REFERENCES
- Part VIII: Treatment Approaches
- 49. The Pharmacotherapy of Anxiety Disorders
- OVERVIEW AND GENERAL PRINCIPLES
- PHARMACOTHERAPY OF PANIC DISORDER AND AGORAPHOBIA
- PHARMACOTHERAPY OF GENERALIZED ANXIETYDISORDER
- PHARMACOTHERAPY OF SOCIAL ANXIETY DISORDER
- CONCLUSIONS AND FUTURE DIRECTIONS
- REFERENCES
- 50. Antipsychotic Drugs
- INTRODUCTION
- HISTORY
- GENERAL CLINICAL CONSIDERATIONS
- DRUG SELECTION
- FIRST-GENERATION (“TYPICAL”) ANTIPSYCHOTICS
- EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA
- NEUROLEPTIC MALIGNANT SYNDROME
- SECOND-GENERATION (“ATYPICAL”) AND THIRD-GENERATION ANTIPSYCHOTICS
- THIRD-GENERATION AND NEWEST ANTIPSYCHOTICS
- DRUG INTERACTIONS WITH ANTIPSYCHOTIC AGENTS
- ONGOING CHALLENGES
- REFERENCES
- 51. Pharmacological Approaches to Depression and Treatment-Resistant Depression
- OVERVIEW
- MECHANISMS OF ACTION
- CLINICAL USES OF ANTIDEPRESSANTS
- CHOICE OF AN ANTIDEPRESSANT
- TREATMENT-RESISTANT DEPRESSION
- DEFINITION OF TREATMENT-RESISTANT DEPRESSION
- STAGING MODELS OF TREATMENT-RESISTANT DEPRESSION
- CLINICAL FEATURES ASSOCIATED WITH TREATMENT-RESISTANT DEPRESSION
- CLINICAL APPROACH TO TREATMENT-RESISTANT DEPRESSION
- COMMON TREATMENT STRATEGIES FOR TREATMENT-RESISTANT DEPRESSION
- COMBINING TWO ANTIDEPRESSANTS WITH DIFFERENT MECHANISMS OF ACTION
- RESEARCH CHALLENGES
- CONCLUSIONS
- Appendix 1 Massachusetts General Hospital Staging Model (MGH-S) definition of TRD – Revised
- REFERENCES
- 52. Device Neuromodulation and Brain Stimulation Therapies
- OVERVIEW
- TRANSCRANIAL MAGNETIC STIMULATION
- ELECTROCONVULSIVE THERAPY
- VAGUS NERVE STIMULATION
- DEEP BRAIN STIMULATION
- ABLATIVE LIMBIC SYSTEM SURGERY
- Conclusion
- REFERENCES
- 53. Lithium and Its Role in Psychiatry
- HISTORICAL CONTEXT
- PHARMACOKINETICS AND PHARMACODYNAMICS
- EVIDENCE FOR LITHIUM’S EFFICACY
- PRINCIPLES OF LITHIUM TREATMENT
- CURRENT CONTROVERSIES AND FUTURE DIRECTIONS
- REFERENCES
- 54. The Use of Antiepileptic Drugs in Psychiatry
- OVERVIEW: HISTORICAL CONTEXT
- PHARMACOKINETICS, PHARMACODYNAMICS, ADVERSE EFFECTS, AND MONITORING
- OTHER ANTICONVULSANTS
- CONCLUSION
- REFERENCES
- 55. Pharmacotherapy of Attention-Deficit Hyperactivity Disorder Across the Life Span
- OVERVIEW
- STIMULANTS
- ATOMOXETINE
- ALPHA-ADRENERGIC AGONISTS
- ALTERNATIVE (NOT APPROVED BY THE FOOD AND DRUG ADMINISTRATION) TREATMENTS FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- SUGGESTED MANAGEMENT STRATEGIES ACROSSTHE LIFE SPAN
- CONCLUSION
- REFERENCES
- 56. Drug–Drug Interactions in Psychopharmacology
- OVERVIEW
- CLASSIFICATION
- PHARMACOKINETICS
- ANTIPSYCHOTICS
- MOOD STABILIZERS
- ANTIDEPRESSANTS
- BENZODIAZEPINES
- PSYCHOSTIMULANTS AND MODAFINIL
- REFERENCES
- 57. Side Effects of Psychotropic Medications
- OVERVIEW
- ANTIDEPRESSANTS
- MOOD STABILIZERS
- ANTIPSYCHOTICS
- ANTI-ANXIETY AND SLEEP AGENTS
- OTHER AGENTS USED IN THE TREATMENT OF PSYCHIATRIC CONDITIONS
- REFERENCES
- 58. Natural Medications in Psychiatry
- OVERVIEW
- EFFICACY AND SAFETY
- MOOD DISORDERS
- ANXIETY AND INSOMNIA
- PREMENSTRUAL AND MENOPAUSAL SYMPTOMS
- COGNITION AND DEMENTIA
- CONCLUSION
- REFERENCES
- Part IX: Special Topics in Psychiatry
- 59. The Suicidal Patient
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- PATHOPHYSIOLOGY
- CLINICAL FEATURES AND DIAGNOSIS
- TREATMENT OF SUICIDE RISK
- DIFFICULTIES IN THE ASSESSMENT OF SUICIDE RISK
- CONCLUSION
- REFERENCES
- 60. Law and Psychiatry
- OVERVIEW
- BASIC CONCEPTS
- INFORMED CONSENT
- TREATMENT REFUSAL
- CONSENT TO PARTICIPATE IN RESEARCH
- CIVIL COMMITMENT
- THE MEDICAL LIABILITY CLIMATE
- MALPRACTICE LIABILITY
- LIABILITY AND MANAGED CARE
- SELECTED AREAS OF LIABILITY RISK IN PSYCHIATRY
- BOUNDARY VIOLATIONS
- REDUCING MALPRACTICE RISK
- CRIMINAL COMPETENCIES
- COMPETENCY TO PLEAD, DECLINE COUNSEL, AND REPRESENT ONESELF
- COMPETENCY TO BE EXECUTED
- CRIMINAL RESPONSIBILITY
- EVALUATIONS OF CRIMINAL RESPONSIBILITY
- CONCLUSION
- REFERENCES
- 61. Intimate Partner Violence
- OVERVIEW
- EPIDEMIOLOGY
- RISK FACTORS FOR VICTIMS AND PERPETRATORS
- CLINICAL PRESENTATION OF PERPETRATORS
- THE NATURE OF THE VIOLENT RELATIONSHIP
- EVALUATION
- DIFFERENTIAL DIAGNOSIS
- TREATMENT CONSIDERATIONS
- CONCLUSION
- REFERENCES
- 62. Psychiatric Correlates and Consequences of Abuse and Neglect
- OVERVIEW
- TYPES OF ABUSE AND NEGLECT
- CHILD ABUSE AND NEGLECT
- ELDER ABUSE AND NEGLECT
- REFERENCES
- SUGGESTED READING
- 63. Patients with Genetic Syndromes
- OVERVIEW
- VARIED APPROACHES TO UNDERSTANDING PSYCHIATRIC GENETICS
- METABOLIC DISEASE
- CONCLUSION
- REFERENCES
- SUGGESTED READING
- 64. Serious Mental Illness
- OVERVIEW
- DEFINITION AND SCOPE OF THE PROBLEM
- COMPLICATIONS OF SERIOUS MENTAL ILLNESS
- COMPREHENSIVE ASSESSMENT
- TREATMENT AND RECOVERY GOALS
- ONGOING CHALLENGES
- REFERENCES
- 65. Community Psychiatry
- OVERVIEW
- TERMS AND DEFINITIONS
- HISTORICAL BACKGROUND
- UNDERLYING PRINCIPLES OF COMMUNITY MENTAL HEALTH
- COMPONENTS AND SERVICES OF COMMUNITY MENTAL HEALTH SYSTEMS
- TRENDS
- CONCLUSION
- REFERENCES
- 66. Culture and Psychiatry
- OVERVIEW
- CULTURAL ASSESSMENT
- IMPACT OF RACE AND ETHNICITY ON PSYCHIATRIC DIAGNOSIS
- CULTURE-BOUND SYNDROMES AND CULTURAL CONCEPT OF DISTRESS
- WORKING WITH INTERPRETERS
- ETHNICITY AND PSYCHOPHARMACOLOGY
- TECHNIQUES TO PROMOTE CULTURAL AWARENESS AND MINIMIZE MISDIAGNOSIS, AND ADVERSE EVENTS
- REFERENCES
- 67. Psychiatric Epidemiology
- OVERVIEW
- EPIDEMIOLOGICAL MEASURES OF DISEASE FREQUENCY
- CRITERIA FOR ASSESSMENT INSTRUMENTS
- DEVELOPMENT OF ASSESSMENT TOOLS
- CONTEMPORARY STUDIES IN PSYCHIATRIC EPIDEMIOLOGY
- EPIDEMIOLOGY OF MAJOR PSYCHIATRIC DISORDERS
- REFERENCES
- 68. Collaborative Care and Primary Care Psychiatry
- OVERVIEW
- EPIDEMIOLOGY
- THE GOALS OF COLLABORATION
- ROLES, RELATIONSHIPS, AND EXPECTATIONS
- MODELS OF TREATMENT AND COLLABORATION
- CHOOSING THE RIGHT MODEL
- CONCLUSION
- REFERENCES
- 69. Geriatric Psychiatry
- OVERVIEW
- MENTAL HEALTH DISORDERS COMMON IN LATE LIFE
- DISASTERS
- CAREGIVER STRESS AND BURDEN
- ELDER ABUSE
- REFERENCES
- 70. Care at the End of Life: Psychiatric and Ethical Aspects
- OVERVIEW
- GOALS OF TREATMENT
- THE ROLE OF THE PSYCHIATRIST
- CHALLENGES FOR CARE PROVIDERS
- PRINCIPLES OF END OF LIFE
- CONCLUSION
- REFERENCES
- 71. Care of LGBTQIA+ Patients
- OVERVIEW
- HISTORICAL CONTEXT WITHIN PSYCHIATRY
- MINORITY STRESS MODEL
- RISK FACTORS, RESILIENCE FACTORS, AND INTERSECTIONALITY
- RESILIENCE FACTORS FOR LGBTQIA+ PATIENTS
- LGBTQIA+ AFFIRMATIVE CARE
- SPECIFIC POPULATIONS
- Potential Psychiatric Impacts of Gender-Affirming Hormone Therapy
- Potential Medication Interactions for Gender-Affirming Hormone Therapy
- Letters of Support for Gender-Affirming Surgeries
- LGBTQIA+ RESOURCES
- CONCLUSION
- REFERENCES
- 72. Obesity and Its Management
- OVERVIEW
- CONCLUSIONS
- CURRENT CONTROVERSIES AND FUTURE CONSIDERATIONS
- REFERENCES
- SUGGESTED READING
- Part X: Neuropsychiatry
- 73. Neuroanatomical Systems Relevant to Neuropsychiatric Disorders
- OVERVIEW
- PREFRONTAL CORTEX
- BASAL GANGLIA
- MEDIAL TEMPORAL LOBE: AMYGDALA AND HIPPOCAMPUS
- CONCLUSION
- REFERENCES
- 74. The Neurological Examination
- OVERVIEW
- THE EXAMINATION
- REFERENCES
- 75. Neuropsychiatric Principles and Differential Diagnosis
- GENERAL PRINCIPLES OF NEUROPSYCHIATRY
- COGNITIVE-BEHAVIORAL NEUROANATOMY
- NEUROPSYCHIATRIC EVALUATION
- NEUROPSYCHIATRIC DIFFERENTIAL DIAGNOSIS
- CLINICAL SIGNS AND SYMPTOMS SUGGESTIVE OF NEUROLOGICAL OR GENERAL MEDICAL CONDITIONS
- TREATMENT PRINCIPLES
- CONCLUSIONS
- REFERENCES
- 76. Neuroimaging in Psychiatry
- OVERVIEW
- STRUCTURAL NEUROIMAGING MODALITIES
- WHEN SHOULD STRUCTURAL NEUROIMAGING BE ORDERED?
- USE OF NEUROIMAGING IN PSYCHIATRIC RESEARCH
- CONCLUSION
- REFERENCES
- 77. Clinical Neurophysiology and Electroencephalography
- OVERVIEW
- THE NORMAL ROUTINE ELECTROENCEPHALOGRAM
- ELECTROENCEPHALOGRAM AND AGE
- ELECTROENCEPHALOGRAM ABNORMALITIES
- CLINICAL UTILITY OF ELECTROENCEPHALOGRAPHY IN PSYCHIATRY
- QUANTITATIVE ELECTROENCEPHALOGRAM
- EVOKED POTENTIALS
- NERVE CONDUCTION
- ELECTROMYOGRAPHY
- REFERENCES
- 78. Epilepsy and Its Psychiatric Manifestations
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- PATHOPHYSIOLOGY
- CLASSIFICATION OF SEIZURES AND EPILEPSIES
- CLINICAL MANIFESTATION OF SEIZURES
- SELECTED EPILEPSIES AND EPILEPTIC SYNDROMES
- EVALUATION OF A PATIENT WITH A SEIZURE
- DIFFERENTIAL DIAGNOSIS
- TREATMENT FOR SEIZURE DISORDERS
- PSYCHIATRIC DISTURBANCES IN EPILEPSY
- NEUROPSYCHOLOGICAL DISTURBANCES IN EPILEPSY
- SUPPORTIVE CARE AND LONG-TERM MANAGEMENT
- REFERENCES
- 79. Differential Diagnosis and Treatment of Headaches
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- GENETICS
- PATHOPHYSIOLOGY
- DIFFERENTIAL DIAGNOSIS
- HEADACHE “RED FLAGS”
- OTHER SECONDARY HEADACHES
- TREATMENT
- HEADACHE SYNDROMES: CLINICAL FEATURES, DIAGNOSIS, AND TREATMENT
- SECONDARY HEADACHES
- CONCLUSION
- ACKNOWLEGMENT
- REFERENCES
- 80. Pathophysiology, Psychiatric Co-morbidity, and Treatment of Pain
- OVERVIEW
- EPIDEMIOLOGY
- PATHOPHYSIOLOGY OF PAIN TRANSMISSION
- CORTICAL SUBSTRATES FOR PAIN AND AFFECT
- INTERACTIONS BETWEEN PAIN AND PSYCHOPATHOLOGY
- PAIN TERMINOLOGY
- ASSESSMENT OF PAIN
- CORE PSYCHOPATHOLOGY AND PAIN-RELATED PSYCHOLOGICAL SYMPTOMS
- PAIN AND CO-MORBID PSYCHIATRIC CONDITIONS
- GENERAL PRINCIPALS OF MULTI-MODAL ANALGESIA
- TREATMENT OF PAIN BEHAVIOR AND THE USE OF MULTI-DISCIPLINARY PAIN CLINICS
- REHABILITATION
- CONCLUSIONS
- REFERENCES
- 81. Psychiatric Aspects of Stroke Syndromes
- OVERVIEW
- EPIDEMIOLOGY
- ISCHEMIC STROKE
- HEMORRHAGIC STROKE
- NEUROPSYCHIATRIC SEQUELAE OF STROKE
- CONCLUSION
- REFERENCES
- 82. Psychiatric Manifestations of Traumatic Brain Disorder
- OVERVIEW
- EPIDEMIOLOGY AND RISK FACTORS
- PATHOPHYSIOLOGY
- CLINICAL FEATURES
- COGNITIVE IMPAIRMENT (TABLE 82.3)
- PERSONALITY AND BEHAVIORAL CHANGES
- PSYCHIATRIC DISORDERS
- DIAGNOSIS
- EVALUATION
- TREATMENT
- CONCLUSION
- REFERENCES
- Websites
- Part XI: Care in Special Settings
- 83. Emergency Psychiatry
- OVERVIEW
- DEMOGRAPHICS
- TYPES OF DELIVERY MODELS
- THE MEDICAL EVALUATION
- THE PSYCHIATRIC INTERVIEW
- THE SAFETY EVALUATION
- PSYCHIATRIC SYMPTOMS AND PRESENTATIONS
- EMERGENCY DEPARTMENT BOARDING OF PATIENTS AWAITING PSYCHIATRIC ADMISSION
- EMERGENCY ASSESSMENT OF CHILDREN
- LEGAL RESPONSIBILITIES OF THE EMERGENCY PSYCHIATRIST
- CONCLUSION
- REFERENCES
- 84. Military Psychiatry
- OVERVIEW
- PSYCHIATRIC SYNDROMES IN THE IMMEDIATE AFTERMATH OF MILITARY OPERATIONS AND TERRORIST EVENTS
- EFFECTS OF RESUSCITATIVE MEDICATIONS
- CONFIDENCE IN A POTENTIALLY TOXIC ENVIRONMENT
- LEVELS OF CLINICAL PREVENTION AND INTERVENTION: SYMPTOMS VERSUS FUNCTION
- FACTORS RELATED TO DEVELOPMENT OF PSYCHIATRIC DISORDERS AMONG SERVICE MEMBERS EXPOSED TO COMBAT OR TERRORIST ATTACK
- MANAGEMENT AND CARE DELIVERY
- MILITARY PSYCHIATRIC CARE IN PEACETIME
- ETHICAL CHALLENGES
- CONCLUSION
- REFERENCES
- 85. Disaster Psychiatry
- OVERVIEW
- HISTORY
- CLINICAL AND RESEARCH CHALLENGES
- CONCLUSION
- REFERENCES
- Websites
- 86. Global Psychiatry and Mental Health in the Post-pandemic Period
- OVERVIEW
- GLOBAL PSYCHIATRY AND THE BURDEN OF MENTAL ILLNESS
- ACTIONS TO MEET THE GLOBAL HEALTH CHALLENGES OF THE FUTURE
- TRAINING AND EDUCATION
- RESEARCH
- RE-FRAMING MENTAL HEALTH CARE TO BETTER SERVE DISADVANTAGED COMMUNITIES
- SELECTED CONCERNS IN GLOBAL PSYCHIATRY
- CONCLUSION
- REFERENCES
- 87. The Interface of Climate and Psychiatry
- OVERVIEW
- BACKGROUND
- PHYSICAL HEALTH CONSEQUENCES OF CLIMATE CHANGE
- PSYCHIATRIC CONSEQUENCES OF CLIMATE CHANGE
- CLIMATE CHANGE AND SYSTEMIC INEQUITY
- CLINICAL CONSIDERATIONS AND POTENTIAL INTERVENTIONS
- PSYCHOLOGICAL BARRIERS TO ACTION
- WHAT WE CAN DO: MITIGATION, ADAPTATION, AND EDUCATION
- REFERENCES
- 88. Sport Psychiatry
- OVERVIEW
- SPORT PSYCHOLOGY
- SPORT PSYCHIATRY
- ATHLETE MENTAL HEALTH AND PSYCHOLOGICAL FACTORS IMPACTING PERFORMANCE
- THE PSYCHOLOGY OF SPORTS INJURIES
- MENTAL SKILLS TO ENHANCE SPORT PERFORMANCE
- SPORT PSYCHOLOGY INTERVENTIONS
- CONCLUSION
- REFERENCES
- 89. School Collaboration and Consultation
- OVERVIEW
- TIERED INTERVENTIONS
- ELIGIBILITY FOR SERVICES AND ACCOMMODATIONS
- CONSENT AND CONFIDENTIALITY OF HEALTH INFORMATION IN SCHOOLS
- CONSIDERATIONS FOR COMMON NEURODEVELOPMENTAL DISORDERS
- SPECIAL CONSIDERATIONS FOR PSYCHIATRIC DISORDERS
- TRANSITION PLANNING
- CONCLUSION
- REFERENCES
- Part XII: Preparing for the Future
- 90. Coping with the Rigors of Psychiatric Practice
- OVERVIEW
- EPIDEMIOLOGY
- ETIOLOGIES FOR STRESS AND BURNOUT
- SPECIAL SITUATIONS IN PSYCHIATRY
- WHEN THE COBBLER’S CHILDREN HAVE NO SHOES
- HEALING THE WOUNDED HEALER
- CONCLUSION
- ACKNOWLEDGMENT
- REFERENCES
- 91. Mindfulness and Resilience
- Abstract
- OVERVIEW
- MINDFULNESS
- RESILIENCE
- THEORETICAL RELATIONSHIP BETWEEN MINDFULNESS AND RESILIENCE
- MINDFULNESS, AUTONOMIC REACTIVITY, AND RESILIENCE
- MINDFULNESS, RESILIENCE, AND THE BRAIN
- MINDFULNESS AND RESILIENCY ACROSS THE LIFE SPAN
- MINDFULNESS AND RESILIENCE IN DIVERSE POPULATIONS
- SYSTEMATIC META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS OF MINDFULNESS FOR RESILIENCE
- SUMMARY OF RESEARCH FINDINGS
- RECOMMENDATIONS FOR CLINICAL PRACTICE
- REFERENCES
- Index
- Confidence is ClinicalKey
- No. of pages: 1056
- Language: English
- Edition: 3
- Published: March 6, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443118449
- eBook ISBN: 9780443118456
TS
Theodore A. Stern
Dr. Theodore A. Stern is the Ned H. Cassem Professor of Psychiatry in the field of Psychosomatic Medicine/Consultation at Harvard Medical School (HMS), Chief Emeritus of The Avery D. Weisman, Psychiatry Consultation Service, and Director of the Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine at the Massachusetts General Hospital (MGH). Dr. Stern has co-authored more than 550 peer-reviewed journal articles and book chapters, and he has edited or authored more than 60 books (including the MGH Handbook of General Hospital Psychiatry, the MGH Psychiatry Update and Board Preparation, Learning About Psychopharmacology, Facing Overweight and Obesity, Facing Pelvic Pain, Facing Memory Loss and Dementia, Facing Serious Mental Illness, and the MGH Study Guide for Psychiatry Exams). Dr. Stern is a Past-President of the Academy of Consultation-Liaison Psychiatry (ACLP) and is the Editor-in-Chief Emeritus of its journal, Psychosomatics (now called Journal of the Academy of Consultation-Liaison Psychiatry). He has won the coveted “Best Teacher Award” from the graduating residents at the MGH/McLean Hospital Psychiatric Residency Training Program, the Cynthia N. Kettyle Teaching Award from the HMS Department of Psychiatry, the MGH Department of Psychiatry’s Award for Exceptional Mentorship in the Clinical Realm, a Lifetime Achievement Award from the Society of Liaison Psychiatry, and the Thomas P. Hackett Award from the ACLP (its highest honor).
Affiliations and expertise
Psychiatrist and Chief Emeritus, Avery D. Weisman Psychiatry Consultation Service, Director, Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine, Massachusetts General Hospital, Boston, MA, USA, Ned H. Cassem Professor of Psychiatry in the Field, Psychosomatic Medicine/Consultation, Harvard Medical School, Boston, MA, USATW
Timothy E. Wilens
Dr. Timothy Wilens is Chief of the Division of Child and Adolescent Psychiatry and is Co-director of the Center for Addiction Medicine at Massachusetts General Hospital (MGH). He is the MGH Trustees Chair in Addiction Medicine and Professor of Psychiatry at Harvard Medical School (HMS). Dr. Wilens earned his MD at the University of Michigan Medical School in Ann Arbor and completed his residency in child, adolescent, and adult psychiatry at the MGH. Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models; and the pharmacotherapy of ADHD across the lifespan. He has published more than 350 peer-reviewed articles concerning these and related topics. He has also co-edited more than 90 book chapters, 5 books, and 350 abstracts and presentations for national and international scientific meetings. Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry and serves on the board or as a scientific reviewer for more than 35 journals.
Affiliations and expertise
Chief of the Division of Child and Adolescent Psychiatry and Co-director of the Center for Addiction Medicine; Massachusetts General Hospital (MGH); MGH Trustees Chair in Addiction Medicine and Professor of Psychiatry, Harvard Medical SchoolMF
Maurizio Fava
Dr. Maurizio Fava is Chair of the Department of Psychiatry at the Massachusetts General Hospital (MGH). Dr. Fava obtained his MD from University of Padova School of Medicine (residency in endocrinology); he completed residency training in psychiatry at the MGH. He founded and was director of the hospital’s Depression Clinical and Research Program (DCRP) from 1990 to 2014. In 2007, he founded and is now Executive Director of the MGH Clinical Trials Network and Institute (CTNI), the first academic CRO specialized in planning and coordination of multi-center clinical trials in psychiatry. Under Dr. Fava’s direction, the DCRP became one of the most highly regarded depression programs in the country, a model for academic programs that link, in a bi-directional fashion, clinical and research work. His prominence in the field is reflected in his role as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, and of the RAPID Network, the NIMH-funded series of studies of novel, rapidly acting antidepressant therapies. Dr. Fava is a world leader in the field of depression. He has authored or co-authored more than 900 original articles published in medical journals with international circulation, edited eight books, and has been successful in obtaining funding as principal or co-principal investigator from both the National Institutes of Health and other sources for a total of more than $150 million.
Affiliations and expertise
Psychiatrist-in-Chief, Department of Psychiatry, Vice Chair, Executive Committee on Research, Massachusetts General Hospital, Boston, MA, USA, Executive Director, Clinical Trials Network & Institute (CTNI), Massachusetts General Hospital, Boston, MA, USA, Associate Dean for Clinical & Translational Research & Slater Family Professor of Psychiatry, Harvard Medical School, Boston, MA, USARead Massachusetts General Hospital Comprehensive Clinical Psychiatry on ScienceDirect